DOI:
10.1055/s-00030576
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics
LinksClose Window
References
Nitti VW, Dmochowski R, Herschorn S. , et al; EMBARK Study Group.
OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.
J Urol 2013;
189 (06) 2186-2193 . Doi: 10.1016/j.juro.2012.12.022
We do not assume any responsibility for the contents of the web pages of other providers.